The DOI matches its Crossref record; 550 of the 550 references it cites were found in a registry or an index.
Organic Cation Transporters in Health and Disease
Abstract
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN)1, OCTN2, multidrug and toxin exclusion (MATE)1, and MATE kidney-specific 2 are polyspecific transporters exhibiting broadly overlapping substrate selectivities. They transport organic cations, zwitterions, and some uncharged compounds and operate as facilitated diffusion systems and/or antiporters. OCTs are critically involved in intestinal absorption, hepatic uptake, and renal excretion of hydrophilic drugs. They modulate the distribution of endogenous compounds such as thiamine, L-carnitine, and neurotransmitters. Sites of expression and functions of OCTs have important impact on energy metabolism, pharmacokinetics, and toxicity of drugs, and on drug–drug interactions. In this work, an overview about the human OCTs is presented. Functional properties of human OCTs, including identified substrates and inhibitors of the individual transporters, are described. Sites of expression are compiled, and data on regulation of OCTs are presented. In addition, genetic variations of OCTs are listed, and data on their impact on transport, drug treatment, and diseases are reported. Moreover, recent data are summarized that indicate complex drug–drug interaction at OCTs, such as allosteric high-affinity inhibition of transport and substrate dependence of inhibitor efficacies. A hypothesis about the molecular mechanism of polyspecific substrate recognition by OCTs is presented that is based on functional studies and mutagenesis experiments in OCT1 and OCT2. This hypothesis provides a framework to imagine how observed complex drug–drug interactions at OCTs arise. Finally, preclinical in vitro tests that are performed by pharmaceutical companies to identify interaction of novel drugs with OCTs are discussed. Optimized experimental procedures are proposed that allow a gapless detection of inhibitory and transported drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
I-TASSER: a unified platform for automated protein structure and function prediction
Roy, A., Kucukural, A., & Zhang, Y. (2010) · Nature Protocols · doi:10.1038/nprot.2010.5 · Cited by 6,170
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Genetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Brown and beige fat: Development, function and therapeutic potential
Harms, M., & Seale, P. (2013) · Nature Medicine · doi:10.1038/nm.3361 · Cited by 2,328
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Herman, J. P., Figueiredo, H., Mueller, N. K., Ulrich-Lai, Y., Ostrander, M. M., Choi, D. C., & Cullinan, W. E. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2003.07.001 · Cited by 1,586
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,475
Structure and Mechanism of the Lactose Permease of Escherichia coli
Abramson, J., Smirnova, I., Kasho, V., Verner, G., Kaback, H. R., & Iwata, S. (2003) · Science · doi:10.1126/science.1088196 · Cited by 1,389
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
The Use of β-Agonists and the Risk of Death and near Death from Asthma
Spitzer, W. O., Suissa, S., Ernst, P., Horwitz, R. I., Habbick, B., Cockcroft, D., Boivin, J.-F., McNutt, M., Buist, A. S., & Rebuck, A. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260801 · Cited by 1,224
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A Helix Propensity Scale Based on Experimental Studies of Peptides and Proteins
Nick Pace, C., & Martin Scholtz, J. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77529-0 · Cited by 1,070
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
Human metabolic individuality in biomedical and pharmaceutical research
CARDIoGRAM, Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., et al. (2011) · Nature · doi:10.1038/nature10354 · Cited by 1,017
Structure and Mechanism of the Glycerol-3-Phosphate Transporter from Escherichia coli
Huang, Y., Lemieux, M. J., Song, J., Auer, M., & Wang, D.-N. (2003) · Science · doi:10.1126/science.1087619 · Cited by 1,016
Lesage, S., Zouali, H., Cézard, J.-P., Colombel, J.-F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339432 · Cited by 997
Carnitine transport and fatty acid oxidation
Longo, N., Frigeni, M., & Pasquali, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.023 · Cited by 996
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment
Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 950
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1008 · Cited by 939
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
Dinis-Oliveira, R. J., Duarte, J. A., Sánchez-Navarro, A., Remião, F., Bastos, M. L., & Carvalho, F. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440701669959 · Cited by 926
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Marin, D., Bazeos, A., Mahon, F.-X., Eliasson, L., Milojkovic, D., Bua, M., Apperley, J. F., Szydlo, R., Desai, R., Kozlowski, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3087 · Cited by 909
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Functional variants of OCTN cation transporter genes are associated with Crohn disease
Peltekova, V. D., Wintle, R. F., Rubin, L. A., Amos, C. I., Huang, Q., Gu, X., Newman, B., Oene, M. V., Cescon, D., Greenberg, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1339 · Cited by 837
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R. A., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 833
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806
New loci associated with kidney function and chronic kidney disease
Köttgen, A., Pattaro, C., Böger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., et al. (2010) · Nature Genetics · doi:10.1038/ng.568 · Cited by 804
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
Rioux, J. D., Daly, M. J., Silverberg, M. S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-223 · Cited by 774
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Carnitine biosynthesis in mammals
Vaz, F. M., & Wanders, R. J. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610417 · Cited by 764
Zeisel, S. H., & Blusztajn, J. K. (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.001413 · Cited by 763
Agmatine: an Endogenous Clonidine-Displacing Substance in the Brain
Li, G., Regunathan, S., Barrow, C. J., Eshraghi, J., Cooper, R., & Reis, D. J. (1994) · Science · doi:10.1126/science.7906055 · Cited by 738
Castagné, V., Moser, P., Roux, S., & Porsolt, R. D. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0810as55 · Cited by 702
Cuthbert, A. P., Fisher, S. A., Mirza, M. M., King, K., Hampe, J., Croucher, P. J. P., Mascheretti, S., Sanderson, J., Forbes, A., Mansfield, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32415 · Cited by 698
Tamai, I., Ohashi, R., Nezu, J.-I., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 697
Active transport of imatinib into and out of cells: implications for drug resistance
Thomas, J., Wang, L., Clark, R. E., & Pirmohamed, M. (2004) · Blood · doi:10.1182/blood-2003-12-4276 · Cited by 643
Drug excretion mediated by a new prototype of polyspecific transporter
Gründemann, D., Gorboulev, V., Gambaryan, S., Veyhl, M., & Koepsell, H. (1994) · Nature · doi:10.1038/372549a0 · Cited by 643
Self-citationCloning and Characterization of Two Human Polyspecific Organic Cation Transporters
GORBOULEV, V., ULZHEIMER, J. C., AKHOUNDOVA, A., ULZHEIMER-TEUBER, I., KARBACH, U., QUESTER, S., BAUMANN, C., LANG, F., BUSCH, A. E., & KOEPSELL, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
Self-citationClinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 636
Tokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., Suzuki, M., Nagasaki, M., Ohtsuki, M., Ono, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1267 · Cited by 626
Nedergaard, J., Golozoubova, V., Matthias, A., Asadi, A., Jacobsson, A., & Cannon, B. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00247-4 · Cited by 615
Ardizzoni, A., Boni, L., Tiseo, M., Fossella, F. V., Schiller, J. H., Paesmans, M., Radosavljevic, D., Paccagnella, A., Zatloukal, P., Mazzanti, P., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk196 · Cited by 612
Discovery of the ergothioneine transporter
Gründemann, D., Harlfinger, S., Golz, S., Geerts, A., Lazar, A., Berkels, R., Jung, N., Rubbert, A., & Schömig, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408624102 · Cited by 608
Serum Creatinine and Renal Function
Levey, A. S., Perrone, R. D., & Madias, N. E. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.002341 · Cited by 605
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
A human transporter protein that mediates the final excretion step for toxic organic cations
Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., & Moriyama, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506483102 · Cited by 571
Nezu, J.-I., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N., Nikaido, H., Sai, Y., Koizumi, A., Shoji, Y., et al. (1999) · Nature Genetics · doi:10.1038/5030 · Cited by 554
Catecholaminergic systems in stress: structural and molecular genetic approaches
Kvetnansky, R., Sabban, E. L., & Palkovits, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2006 · Cited by 548
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney
Motohashi, H., Sakurai, Y., Saito, H., Masuda, S., Urakami, Y., Goto, M., Fukatsu, A., Ogawa, O., & Inui, K.-I. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134866 · Cited by 508
Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 497
Molecular mechanism of action of metformin: old or new insights?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Diabetologia · doi:10.1007/s00125-013-2991-0 · Cited by 479
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
Shu, Y., Brown, C., Castro, R., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E., Brett, C., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 477
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
Sun, L., Zeng, X., Yan, C., Sun, X., Gong, X., Rao, Y., & Yan, N. (2012) · Nature · doi:10.1038/nature11524 · Cited by 471
Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1
Tamai, I., Yabuuchi, H., Nezu, J.-I., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01441-5 · Cited by 458
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Self-citationCiarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Self-citationOsborne, R., Joel, S., Trew, D., & Slevin, M. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.2 · Cited by 444
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Human UGT2B7 catalyzes morphine glucuronidation.
Coffman, B. L., Rios, G. R., King, C. D., et al. (1997) · PubMed · Cited by 426
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Structural advances for the major facilitator superfamily (MFS) transporters
Yan, N. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.003 · Cited by 418
Tanihara, Y., Masuda, S., Sato, T., Katsura, T., Ogawa, O., & Inui, K.-I. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.010 · Cited by 417
Cloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Kekuda, R., Prasad, P. D., Wu, X., Wang, H., Fei, Y.-J., Leibach, F. H., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.15971 · Cited by 409
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.139 · Cited by 399
Mammalian and bacterial sugar transport proteins are homologous
Maiden, M. C. J., Davis, E. O., Baldwin, S. A., Moore, D. C. M., & Henderson, P. J. F. (1987) · Nature · doi:10.1038/325641a0 · Cited by 398
KARPATI, G., CARPENTER, S., ENGEL, A. G., WATTERS, G., ALLEN, J., ROTHMAN, S., KLASSEN, G., & MAMER, O. A. (1975) · Neurology · doi:10.1212/wnl.25.1.16 · Cited by 397
Choline: an essential nutrient for humans
Zeisel, S. H. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00349-x · Cited by 392
Nishimura, M., & Naito, S. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.452 · Cited by 388
Structure of the Multidrug Transporter EmrD from Escherichia coli
Yin, Y., He, X., Szewczyk, P., Nguyen, T., & Chang, G. (2006) · Science · doi:10.1126/science.1125629 · Cited by 387
Nies, A. T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U. M., Keppler, D., Schwab, M., & Schaeffeler, E. (2009) · Hepatology · doi:10.1002/hep.23103 · Cited by 387
Self-citationMolecular basis of ligand recognition and transport by glucose transporters
Deng, D., Sun, P., Yan, C., Ke, M., Jiang, X., Xiong, L., Ren, W., Hirata, K., Yamamoto, M., Fan, S., et al. (2015) · Nature · doi:10.1038/nature14655 · Cited by 384
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
dos Santos, N. A. G., Carvalho Rodrigues, M. A., Martins, N. M., & dos Santos, A. C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0821-7 · Cited by 378
Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 377
Nies, A. T., Koepsell, H., Damme, K., & Schwab, M. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_3 · Cited by 375
Self-citationMolecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E. (1998) · Nature Neuroscience · doi:10.1038/1557 · Cited by 374 · cited 4×
“OCT2 (Slc22A2) was cloned from rat (Okuda et al., 1996), OCT3 (SLC22A3) from human (Gründemann et al., 1998) and rat (Kekuda et al., 1998), novel OCT (OCTN) 1 from human (SLC22A4) (Tamai et al., 1997), and OCTN2 from human (SLC22A5) and rat (Wu et al., 1998b) (SlcA5) (Sekine et al., 1998).”
BackgroundInfluentialMasuda, S., Terada, T., Yonezawa, A., Tanihara, Y., Kishimoto, K., Katsura, T., Ogawa, O., & Inui, K.-I. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030205 · Cited by 371
Wu, X., Kekuda, R., Huang, W., Fei, Y.-J., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32776 · Cited by 370
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1
Kimura, N., Masuda, S., Tanihara, Y., Ueo, H., Okuda, M., Katsura, T., & Inui, K.-I. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.379 · Cited by 360
cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2
Okuda, M., Saito, H., Urakami, Y., Takano, M., & Inui, K.-I. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1056 · Cited by 352
Tzvetkov, M. V., Vormfelde, S. V., Balen, D., Meineke, I., Schmidt, T., Sehrt, D., Sabolić, I., Koepsell, H., & Brockmöller, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.92 · Cited by 349
Self-citationPharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Yonezawa, A., Masuda, S., Yokoo, S., Katsura, T., & Inui, K.-I. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110346 · Cited by 344
Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney, D. S. (1998) · PubMed · Cited by 342
Wu, X., Prasad, P. D., Leibach, F. H., & Ganapathy, V. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8669 · Cited by 341
Impact of CYP2D6 genotype on postoperative tramadol analgesia
Stamer, U. M., Lehnen, K., Höthker, F., Bayerer, B., Wolf, S., Hoeft, A., & Stuber, F. (2003) · Pain · doi:10.1016/s0304-3959(03)00212-4 · Cited by 333
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 332
Self-citationWhite, D. L., Saunders, V. A., Dang, P., Engler, J., Venables, A., Zrim, S., Zannettino, A., Lynch, K., Manley, P. W., & Hughes, T. (2007) · Blood · doi:10.1182/blood-2007-06-093617 · Cited by 331
Wu, X., Huang, W., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35056-6 · Cited by 330
Marin, D., Milojkovic, D., Olavarria, E., Khorashad, J. S., de Lavallade, H., Reid, A. G., Foroni, L., Rezvani, K., Bua, M., Dazzi, F., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162388 · Cited by 328
Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
Ho, G. Y., Woodward, N., & Coward, J. I. G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.014 · Cited by 325
Yabuuchi, H., Tamai, I., Nezu, J.-I., Sakamoto, K., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38199-6 · Cited by 316
Geier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 314
l-Carnitine and Acetyl-l-carnitine Roles and Neuroprotection in Developing Brain
Ferreira, G. C., & McKenna, M. C. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2288-7 · Cited by 312
ORGANIC CATION TRANSPORTERS IN INTESTINE, KIDNEY, LIVER, AND BRAIN
Koepsell, H. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.243 · Cited by 310
Self-citationTreem, W. R., Stanley, C. A., Finegold, D. N., Hale, D. E., & Coates, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192006 · Cited by 309
Kantarjian, H. M., Talpaz, M., O'Brien, S., Giles, F., Garcia-Manero, G., Faderl, S., Thomas, D., Shan, J., Rios, M. B., & Cortes, J. (2003) · Blood · doi:10.1182/blood-2002-05-1451 · Cited by 306
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300
Helms, C., Cao, L., Krueger, J. G., Wijsman, E. M., Chamian, F., Gordon, D., Heffernan, M., Daw, J. A. W., Robarge, J., Ott, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1268 · Cited by 299
Repurposing metformin for the prevention of cancer and cancer recurrence
Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V., & Ford, L. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4372-6 · Cited by 297
The Key Role of Macrophages in the Immunopathogenesis of Inflammatory Bowel Disease
Mahida, Y. R. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00004 · Cited by 293
OSMORECEPTORS IN THE CENTRAL NERVOUS SYSTEM
Bourque and, C. W., & Oliet, S. H. R. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.601 · Cited by 293
Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice
Tamai, I., Ohashi, R., Nezu, J.-I., Sai, Y., Kobayashi, D., Oku, A., Shimane, M., & Tsuji, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005340200 · Cited by 292
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
True, L., Coleman, I., Hawley, S., Huang, C.-Y., Gifford, D., Coleman, R., Beer, T. M., Gelmann, E., Datta, M., Mostaghel, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603678103 · Cited by 291
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Diabetes · doi:10.2337/db08-1028 · Cited by 290
Newstead, S., Drew, D., Cameron, A. D., Postis, V. L. G., Xia, X., Fowler, P. W., Ingram, J. C., Carpenter, E. P., Sansom, M. S. P., McPherson, M. J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.309 · Cited by 290
Shu, Y., Leabman, M. K., Feng, B., Mangravite, L. M., Huang, C. C., Stryke, D., Kawamoto, M., Johns, S. J., DeYoung, J., Carlson, E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730858100 · Cited by 285
Pabla, N., Murphy, R. F., Liu, K., & Dong, Z. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90545.2008 · Cited by 283
Reduction of metformin renal tubular secretion by cimetidine in man.
Somogyi, A., Stockley, C., Keal, J., Rolan, P., & Bochner, F. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03090.x · Cited by 282
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Wang, Z.-J., Yin, O. Q. P., Tomlinson, B., & Chow, M. S. S. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328302cd41 · Cited by 281
Hayer‐Zillgen, M., Brüss, M., & Bönisch, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704785 · Cited by 278
Dujic, T., Zhou, K., Donnelly, L. A., Tavendale, R., Palmer, C. N. A., & Pearson, E. R. (2015) · Diabetes · doi:10.2337/db14-1388 · Cited by 278
Wang, L., Giannoudis, A., Lane, S., Williamson, P. R., Pirmohamed, M., & Clark, R. E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100268 · Cited by 277
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
BACTERIAL REDUCTION OF TRIMETHYLAMINE OXIDE
Barrett, E. L., & Kwan, H. S. (1985) · Annual Review of Microbiology · doi:10.1146/annurev.mi.39.100185.001023 · Cited by 275
Bailey, C. J., Wilcock, C., & Scarpello, J. H. B. (2008) · Diabetologia · doi:10.1007/s00125-008-1053-5 · Cited by 275
Structure of a fucose transporter in an outward-open conformation
Dang, S., Sun, L., Huang, Y., Lu, F., Liu, Y., Gong, H., Wang, J., & Yan, N. (2010) · Nature · doi:10.1038/nature09406 · Cited by 274
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J.-I., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273
Structure of a cation-bound multidrug and toxic compound extrusion transporter
He, X., Szewczyk, P., Karyakin, A., Evin, M., Hong, W.-X., Zhang, Q., & Chang, G. (2010) · Nature · doi:10.1038/nature09408 · Cited by 272
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
Song, I., Shin, H., Shim, E., Jung, I., Kim, W., Shon, J., & Shin, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.61 · Cited by 268
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain
Engel, K., Zhou, M., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 267
Limited evolutionary conservation of imprinting in the human placenta
Monk, D., Arnaud, P., Apostolidou, S., Hills, F. A., Kelsey, G., Stanier, P., Feil, R., & Moore, G. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511031103 · Cited by 264
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
Müller, J., Lips, K. S., Metzner, L., Neubert, R. H. H., Koepsell, H., & Brandsch, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.011 · Cited by 262
Self-citationEdwards, R. R., Moric, M., Husfeldt, B., Buvanendran, A., & Ivankovich, O. (2005) · Pain Medicine · doi:10.1111/j.1526-4637.2005.05007.x · Cited by 261
Thornalley, P. J., Babaei-Jadidi, R., Al Ali, H., Rabbani, N., Antonysunil, A., Larkin, J., Ahmed, A., Rayman, G., & Bodmer, C. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0771-4 · Cited by 260
Christensen, M. M. H., Brasch-Andersen, C., Green, H., Nielsen, F., Damkier, P., Beck-Nielsen, H., & Brosen, K. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834c0010 · Cited by 259
Drozdzik, M., Gröer, C., Penski, J., Lapczuk, J., Ostrowski, M., Lai, Y., Prasad, B., Unadkat, J. D., Siegmund, W., & Oswald, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500330y · Cited by 258
Reese, M. J., Savina, P. M., Generaux, G. T., Tracey, H., Humphreys, J. E., Kanaoka, E., Webster, L. O., Harmon, K. A., Clarke, J. D., & Polli, J. W. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048918 · Cited by 254
Zhou, M., Xia, L., & Wang, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015495 · Cited by 251
Kaiser, R., Sezer, O., Papies, A., Bauer, S., Schelenz, C., Tremblay, P.-B., Possinger, K., Roots, I., & Brockmöller, J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.064 · Cited by 251
Agmatine, the bacterial amine, is widely distributed in mammalian tissues
Raasch, W., Regunathan, S., Li, G., & Reis, D. J. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00226-v · Cited by 250
Structural basis for the drug extrusion mechanism by a MATE multidrug transporter
Tanaka, Y., Hipolito, C. J., Maturana, A. D., Ito, K., Kuroda, T., Higuchi, T., Katoh, T., Kato, H. E., Hattori, M., Kumazaki, K., et al. (2013) · Nature · doi:10.1038/nature12014 · Cited by 250
Yokoo, S., Yonezawa, A., Masuda, S., Fukatsu, A., Katsura, T., & Inui, K.-I. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.004 · Cited by 250
Chen, Y., Li, S., Brown, C., Cheatham, S., Castro, R. A., Leabman, M. K., Urban, T. J., Chen, L., Yee, S. W., Choi, J. H., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832cc7e9 · Cited by 248
Interaction of the Type IIa Na/Pi Cotransporter with PDZ Proteins
Gisler, S. M., Stagljar, I., Traebert, M., Bacic, D., Biber, J., & Murer, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008745200 · Cited by 243
Lepist, E.-I., Zhang, X., Hao, J., Huang, J., Kosaka, A., Birkus, G., Murray, B. P., Bannister, R., Cihlar, T., Huang, Y., et al. (2014) · Kidney International · doi:10.1038/ki.2014.66 · Cited by 242
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
Chen, L., Shu, Y., Liang, X., Chen, E. C., Yee, S. W., Zur, A. A., Li, S., Xu, L., Keshari, K. R., Lin, M. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314939111 · Cited by 237
Crystal structure of a eukaryotic phosphate transporter
Pedersen, B. P., Kumar, H., Waight, A. B., Risenmay, A. J., Roe-Zurz, Z., Chau, B. H., Schlessinger, A., Bonomi, M., Harries, W., Sali, A., et al. (2013) · Nature · doi:10.1038/nature12042 · Cited by 235
Interaction of Imatinib with Human Organic Ion Carriers
Hu, S., Franke, R. M., Filipski, K. K., Hu, C., Orwick, S. J., de Bruijn, E. A., Burger, H., Baker, S. D., & Sparreboom, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4913 · Cited by 232
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.15 · Cited by 229
Alternating access mechanism in the POT family of oligopeptide transporters
Solcan, N., Kwok, J., Fowler, P. W., Cameron, A. D., Drew, D., Iwata, S., & Newstead, S. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.157 · Cited by 225
Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract
Meier, Y., Eloranta, J. J., Darimont, J., Ismair, M. G., Hiller, C., Fried, M., Kullak-Ublick, G. A., & Vavricka, S. R. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013342 · Cited by 223
Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium
Lips, K. S., Volk, C., Schmitt, B. M., Pfeil, U., Arndt, P., Miska, D., Ermert, L., Kummer, W., & Koepsell, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0363oc · Cited by 221
Self-citationDisruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity
Nakamura, T., Yonezawa, A., Hashimoto, S., Katsura, T., & Inui, K.-I. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.019 · Cited by 221
Role of transporters in drug interactions
Han, H.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-1107-y · Cited by 220
Disposition of metformin (N,N‐dimethylbiguanide) in man
Sirtori, C. R., Franceschini, G., Galli-Kienle, M., Cighetti, G., Galli, G., Bondioli, A., & Conti, F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978246683 · Cited by 220
Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 217
Kerb, R., Brinkmann, U., Chatskaia, N., Gorbunov, D., Gorboulev, V., Mornhinweg, E., Keil, A., Eichelbaum, M., & Koepsell, H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00002 · Cited by 214
Self-citationChronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake
Stanley, C. A., DeLeeuw, S., Coates, P. M., Vianey‐Liaud, C., Divry, P., Bonnefont, J., Saudubray, J., Haymond, M., Trefz, F. K., Breningstall, G. N., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410300512 · Cited by 213
Localization of organic cation transporters OCT1 and OCT2 in rat kidney
Karbach, U., Kricke, J., Meyer-Wentrup, F., Gorboulev, V., Volk, C., Loffing-Cueni, D., Kaissling, B., Bachmann, S., & Koepsell, H. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f679 · Cited by 212
Self-citationIto, S., Kusuhara, H., Yokochi, M., Toyoshima, J., Inoue, K., Yuasa, H., & Sugiyama, Y. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184986 · Cited by 211
Amphoux, A., Vialou, V., Drescher, E., Brüss, M., La Cour, C. M., Rochat, C., Millan, M. J., Giros, B., Bönisch, H., & Gautron, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.005 · Cited by 211
Porsolt, R. D., Brossard, G., Hautbois, C., & Roux, S. (2001) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0810as14 · Cited by 210
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
Lutterbach, B., & Hiebert, S. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00014-7 · Cited by 209
Creatinine Transport by Basolateral Organic Cation Transporter hOCT2 in the Human Kidney
Urakami, Y., Kimura, N., Okuda, M., & Inui, K.-I. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029286.45788.ad · Cited by 207
Chen, L., Pawlikowski, B., Schlessinger, A., More, S. S., Stryke, D., Johns, S. J., Portman, M. A., Chen, E., Ferrin, T. E., Sali, A., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833fe789 · Cited by 207
Gene Knockout and Metabolome Analysis of Carnitine/Organic Cation Transporter OCTN1
Kato, Y., Kubo, Y., Iwata, D., Kato, S., Sudo, T., Sugiura, T., Kagaya, T., Wakayama, T., Hirayama, A., Sugimoto, M., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0076-z · Cited by 206
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB
Van Damme, P., Lasa, M., Polevoda, B., Gazquez, C., Elosegui-Artola, A., Kim, D. S., De Juan-Pardo, E., Demeyer, K., Hole, K., Larrea, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210303109 · Cited by 206
hOCT 1 and resistance to imatinib
Crossman, L. C., Druker, B. J., & Deininger, M. W. N. (2005) · Blood · doi:10.1182/blood-2005-02-0694 · Cited by 206
Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1
Busch, A. E., Quester, S., Ulzheimer, J. C., Waldegger, S., Gorboulev, V., Arndt, P., Lang, F., & Koepsell, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32599 · Cited by 206
Self-citationTzvetkov, M. V., dos Santos Pereira, J. N., Meineke, I., Saadatmand, A. R., Stingl, J. C., & Brockmöller, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.019 · Cited by 206
Neuhoff, S., Ungell, A.-L., Zamora, I., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1025032511040 · Cited by 206
Zwart, R., Verhaagh, S., Buitelaar, M., Popp-Snijders, C., & Barlow, D. P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4188-4196.2001 · Cited by 205
Innocenti, F., Cooper, G. M., Stanaway, I. B., Gamazon, E. R., Smith, J. D., Mirkov, S., Ramirez, J., Liu, W., Lin, Y. S., Moloney, C., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002078 · Cited by 204
Cui, M., Aras, R., Christian, W. V., Rappold, P. M., Hatwar, M., Panza, J., Jackson-Lewis, V., Javitch, J. A., Ballatori, N., Przedborski, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900358106 · Cited by 202
Metformin and digestive disorders
Bouchoucha, M., Uzzan, B., & Cohen, R. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.002 · Cited by 201
Cook, M. N., Girman, C. J., Stein, P. P., & Alexander, C. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02078.x · Cited by 197
Duan, H., & Wang, J. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170142 · Cited by 197
Cloning of the Human Thiamine Transporter, a Member of the Folate Transporter Family
Dutta, B., Huang, W., Molero, M., Kekuda, R., Leibach, F. H., Devoe, L. D., Ganapathy, V., & Prasad, P. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31925 · Cited by 196
Minematsu, T., & Giacomini, K. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0731 · Cited by 196
Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency
Wang, Y., Ye, J., Ganapathy, V., & Longo, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2356 · Cited by 195
Tsuda, M., Terada, T., Ueba, M., Sato, T., Masuda, S., Katsura, T., & Inui, K.-I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147918 · Cited by 194
Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genes
Zwart, R., Sleutels, F., Wutz, A., Schinkel, A. H., & Barlow, D. P. (2001) · Genes & Development · doi:10.1101/gad.206201 · Cited by 194
Stocker, S. L., Morrissey, K. M., Yee, S. W., Castro, R. A., Xu, L., Dahlin, A., Ramirez, A. H., Roden, D. M., Wilke, R. A., McCarty, C. A., et al. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.210 · Cited by 193
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
Leabman, M. K., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., Clark, A. G., Herskowitz, I., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200207000-00007 · Cited by 191
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Ohashi, R., Tamai, I., Nezu, J.-I., Nikaido, H., Hashimoto, N., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12847-7 · Cited by 185
Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
Nies, A. T., Hofmann, U., Resch, C., Schaeffeler, E., Rius, M., & Schwab, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022163 · Cited by 184
Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
Ritz, B. R., Manthripragada, A. D., Costello, S., Lincoln, S. J., Farrer, M. J., Cockburn, M., & Bronstein, J. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800277 · Cited by 184
Zhou, K., Donnelly, L. A., Kimber, C. H., Donnan, P. T., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Palmer, C. N. A., et al. (2009) · Diabetes · doi:10.2337/db08-0896 · Cited by 184
Cited by
Structural basis of organic cation transporter-3 inhibition
Khanppnavar, B., Maier, J., Herborg, F., Gradisch, R., Lazzarin, E., Luethi, D., Yang, J.-W., Qi, C., Holy, M., Jäntsch, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34284-8 · Cited by 77
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Yue, Q., Leng, X., Xie, N., Zhang, Z., Yang, D., & Hoi, M. P. M. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70079 · Cited by 48
Metadata
- Authors
- Koepsell, H.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 72
- Issue
- 1
- Pages
- 253-319
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2994850615
- Cited by
- 297
- References
- 550
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.